in a prospective study , 157 patients with prolonged aplasia ( pmn less than 500/mm3 during more than 21 days ) , hospitalized in a protected environment unit , were randomly assigned to receive ceftazidime alone or cefotaxime + tobramycin for initial febrile episodes .
C0007559
ceftazidime
C0015967
febrile